What is the current valuation of the home infusion-therapy-devices market in China?

The market valuation was $512.25 Million in 2024. Read More

What is the projected market size for the home infusion-therapy-devices market in China by 2035?

The projected valuation for 2035 is $884.4 Million. Read More

What is the expected CAGR for the home infusion-therapy-devices market in China during the forecast period 2025 - 2035?

The expected CAGR is 5.09% during the forecast period. Read More

Which device type segment had the highest valuation in 2024?

The IV Sets segment had the highest valuation at $220.0 Million in 2024. Read More

What is the projected valuation for the Smart Infusion Pumps segment by 2035?

The Smart Infusion Pumps segment is projected to reach $350.0 Million by 2035. Read More

Which application segment is expected to grow the most in the home infusion-therapy-devices market?

The Hydration Therapy segment is projected to grow significantly, reaching $234.4 Million by 2035. Read More

What was the valuation of the homecare settings end user segment in 2024?

The homecare settings segment was valued at $200.0 Million in 2024. Read More

Which key player is recognized for its leadership in the home infusion-therapy-devices market?

Baxter International Inc is recognized as a key player in the market. Read More

What is the projected growth for the Portable Infusion Devices segment by 2035?

The Portable Infusion Devices segment is projected to grow to $180.0 Million by 2035. Read More

How does the valuation of the Nursing Homes end user segment compare to others in 2024?

The Nursing Homes segment was valued at $62.25 Million, the lowest among the end user segments in 2024. Read More

China Home Infusion Therapy Devices Market

ID: MRFR/Pharma/49007-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

China Home Infusion Therapy Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End Users (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Growth Outlook & Industry Forecast 2025 To 2035

China Home Infusion Therapy Devices Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Device Type (USD Million)
  1. 4.1.1 Infusion Pumps
  2. 4.1.2 IV Sets
  3. 4.1.3 Needles and Cannulas
  4. 4.1.4 Syringe Pumps
  5. 4.1.5 Infusion Accessories
2. 4.2 Life Sciences, BY Application (USD Million)
  1. 4.2.1 Antibiotics
  2. 4.2.2 Chemotherapy
  3. 4.2.3 Enteral Nutrition
  4. 4.2.4 Pain Management
  5. 4.2.5 Hydration Therapy
3. 4.3 Life Sciences, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Homecare Settings
  3. 4.3.3 Ambulatory Surgical Centers
  4. 4.3.4 Nursing Homes
4. 4.4 Life Sciences, BY Product (USD Million)
  1. 4.4.1 Portable Infusion Devices
  2. 4.4.2 Complex Infusion Systems
  3. 4.4.3 Smart Infusion Pumps
  4. 4.4.4 Accessories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Baxter International Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 B. Braun Melsungen AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fresenius Kabi AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic plc (IE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Smiths Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 ICU Medical Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Terumo Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Halyard Health Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Zyno Medical LLC (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY DEVICE TYPE
3. 6.3 CHINA MARKET ANALYSIS BY APPLICATION
4. 6.4 CHINA MARKET ANALYSIS BY END USER
5. 6.5 CHINA MARKET ANALYSIS BY PRODUCT
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY DEVICE TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Life Sciences Market Segmentation

Life Sciences By Device Type (USD Million, 2025-2035)

Infusion Pumps
IV Sets
Needles and Cannulas
Syringe Pumps
Infusion Accessories

Life Sciences By Application (USD Million, 2025-2035)

Antibiotics
Chemotherapy
Enteral Nutrition
Pain Management
Hydration Therapy

Life Sciences By End User (USD Million, 2025-2035)

Hospitals
Homecare Settings
Ambulatory Surgical Centers
Nursing Homes

Life Sciences By Product (USD Million, 2025-2035)

Portable Infusion Devices
Complex Infusion Systems
Smart Infusion Pumps
Accessories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”